What is LumiGenics?
LumiGenics LLC operates as a Contract Research Organization (CRO) with a specialized focus on preclinical optical imaging. The company provides advanced imaging solutions designed to accelerate research and development initiatives across the life sciences. Its services are tailored for pharmaceutical companies, biotechnology firms, and academic institutions that require cutting-edge imaging technologies to support preclinical studies and enhance drug development outcomes. LumiGenics is dedicated to delivering high-quality imaging services that contribute to improved research efficacy.
How much funding has LumiGenics raised?
LumiGenics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in LumiGenics
PPP
Public-Private Partnership
What's next for LumiGenics?
The substantial late-stage funding indicates LumiGenics is poised for significant expansion and operational scaling. This capital infusion is likely to be directed towards enhancing its imaging technology portfolio, expanding its service offerings, and potentially broadening its client base within the pharmaceutical and biotech industries. The strategic nature of the recent investment suggests a strong alignment with investor goals, pointing towards a future focused on solidifying its market position and driving innovation in preclinical research.
See full LumiGenics company page
